Table 1.

Antisense Oligonucleotides (ASOs) to Treat Duchenne Muscular Dystrophy (DMD).

Name	ASO			Target exon	Phase
	Nucleic acid	Size	Route
Eteplirsen	PMO	25	IV	51	Approved
Golodirsen	PMO	25	IV	53	Approved
Viltolarsen	PMO	21	IV	53	Approved
Casimersen	PMO	25	IV	45	Approval stage
Renadirsen	ENA/2'RNA	18	SC	45	I/II

PMO: phosphorodiamidate morpholino; ENA: 2'-O,4'-C-ethylene-bridged nucleic acid; 2'RNA: 2'-O-methyl RNA; IV: intravenous injection; SC: subcutaneous injection